You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemia

Article metrics

Article menu
XML
Case report
Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemia

 

Online download statistics by month:

Online download statistics by month: November 2020 to August 2024

AbstractFullPdf
Nov 202019819863
Dec 2020323323104
Jan 202110010048
Feb 2021848431
Mar 202110210227
Apr 2021777719
May 2021777719
Jun 202110910944
Jul 2021747434
Aug 2021696969
Sep 2021585853
Oct 2021868665
Nov 2021706936
Dec 2021757527
Jan 2022686920
Feb 2022626212
Mar 2022595919
Apr 2022616219
May 2022616226
Jun 2022585912
Jul 202269709
Aug 2022888818
Sep 2022747427
Oct 2022808234
Nov 202257579
Dec 202271718
Jan 2023727213
Feb 2023909019
Mar 2023747519
Apr 2023585825
May 2023686821
Jun 2023737316
Jul 2023616118
Aug 2023595912
Sep 2023696921
Oct 2023616215
Nov 2023757625
Dec 2023717216
Jan 2024434514
Feb 2024525211
Mar 2024646468
Apr 2024585837
May 2024596223
Jun 2024666519
Jul 2024747523
Aug 202457552
Total361436271269